Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 12/20 | 0.42 |
| ▸ | DRD3 | P35462 | 3/20 | 0.42 |
| ▸ | DRD2 | P14416 | 6/20 | 0.41 |
| ▸ | HTR2A | P28223 | 4/20 | 0.41 |
| ▸ | HTR1A | P08908 | 3/20 | 0.41 |
| ▸ | HTR7 | P34969 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL322881 | 0.72 | DRD2 (0.48) | DRD3DRD2 | |
| SCHEMBL322882 | 0.70 | HTR6 (0.43) | HTR6DRD3DRD2HTR2AHTR1A | |
| SCHEMBL1626963 | 0.68 | DRD2 (0.65) | DRD3DRD2HTR2AHTR1A | |
| SCHEMBL4536932 | 0.68 | DRD2 (0.65) | DRD3DRD2HTR2AHTR1A | |
| SCHEMBL8538844 | 0.68 | DRD2 (0.65) | DRD3DRD2HTR2AHTR1A | |
| SCHEMBL357358 | 0.68 | DRD2 (0.65) | DRD3DRD2HTR2AHTR1A | |
| SCHEMBL6422590 | 0.68 | SLC6A2 (0.38) | HTR6DRD3DRD2HTR2AHTR1A | |
| SCHEMBL28845061 | 0.67 | DRD2 (0.63) | DRD3DRD2HTR2AHTR1A | |
| SCHEMBL28148490 | 0.67 | DRD2 (0.63) | DRD3DRD2HTR2AHTR1A | |
| Hydrochloric Acid SCHEMBL1711121 | 0.67 | DRD2 (0.63) | DRD3DRD2HTR2AHTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022134642-A1 | AROMATIC HETEROCYCLIC COMPOUND, AND PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF | 湃隆生物科技有限公司（香港） | 2022-06-30 | — | — | WO | disclosed |